Market Currents
Array BioPharma (ARRY +2.4%) trades up after announcing positive results from Phase 1 and 2...
-
Monday, December 12, 2011, 12:52 PM ETArray BioPharma (ARRY +2.4%) trades up after announcing positive results from Phase 1 and 2 testing of its kinesin spindle protein inhibitor, ARRY-520, yesterday at the annual meeting of the American Society of Hematology in San Diego, California.
Other date
Latest Articles
